Your browser doesn't support javascript.
loading
[Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.
Liu, Jia; Dong, Bing-Fei; Wang, Pei-Song; Ren, Pei-You; Xue, Shuai; Zhang, Xiao-Nan; Han, Zhe; Chen, Guang.
Afiliación
  • Liu J; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • Dong BF; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • Wang PS; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • Ren PY; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • Xue S; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • Zhang XN; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • Han Z; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
  • Chen G; Department of Thyroid Surgery, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Oncol Rep ; 47(5)2022 May.
Article en En | MEDLINE | ID: mdl-35234269

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Grecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Grecia